NVAX FY 2008 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-29.7% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$34M-3229.3% margin

Net Income

-$36M-3388.1% margin

EPS (Diluted)

$-10.58

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$30M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$77M

Total Liabilities

$31M

Stockholders' Equity

$45M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-29.7%
Gross Profit	$1M	$1M	-17.6%
Operating Income	-$34M	-$30M	-13.5%
Net Income	-$36M	-$35M	-3.7%